HOUSTON & BOSTON– The CUBIO Innovation Center of Houston, Texas has entered into a partnership agreement with CreaGen, Inc., based outside of Boston in Woburn, Massachusetts. CUBIO’s members in the biotechnology field who need advanced chemistry-based lab services that exceed those available at CUBIO’s labs will be connected to CreaGen for their top-notch discovery and development chemistry contract research services. In return, CreaGen will recommend any client companies to CUBIO who match the requirements for CUBIO’s ongoing Life Science Funding Program (LSFP).
LSFP is an ongoing initiative for mid-to-late-stage biotechnology and medical device companies that helps them to launch a branch of their business in Suzhou, China while providing them with the necessary initial funding, regulatory guidance, and IP protections to make this launch a success. Applying to LSFP is free, with the next upcoming application deadline on Friday, July 30, 2021.
“We are pleased to launch this partnership, connecting CUBIO in Houston to CreaGen in Boston’s Biotech HUB,” commented Raj Rajur, CEO of CreaGen. He added, “We support all modalities involving chemistry, which will enable design, synthesis, biological assays, compound management and development for our clients.”
Wesley Okeke, CEO of CUBIO, noted, “We are excited to join in partnership with Boston-based CreaGen, a Contract Research Organization that will provide CUBIO members with chemical expertise and research and development facilities that many startup biotech and healthcare companies do not have or cannot afford to build themselves in the early stages of starting their businesses or spinning out from academia.” (IANS)